Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Sc Pharmaceuticals Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$5.53 - $15.4 $200,219 - $557,572	-36,206 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $420,713 - $627,087	36,206 New	36,206 $449,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37.1M

Call Options Held

110K

Put Options Held

12.1K

Orbimed Advisors LLC San Diego, CA

6.06M
Shares

$21 Million
0.65% of portfolio
Rubric Capital Management LP New York, NY

4.78M
Shares

$16.5 Million
0.61% of portfolio
Aigh Capital Management LLC Baltimore, MD

4.12M
Shares

$14.3 Million
7.6% of portfolio
King Luther Capital Management Corp Fort Worth, TX

2.23M
Shares

$7.7 Million
0.04% of portfolio
Suvretta Capital Management, LLC New York, NY

2.05M
Shares

$7.09 Million
0.37% of portfolio

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $94.8M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account